Saint Gely du Fesc, France

Claude Bernhart

USPTO Granted Patents = 12 


Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 205(Granted Patents)


Location History:

  • St. Gely du Fesc, FR (1982)
  • Saint Gely du Fesc, FR (1982 - 2006)

Company Filing History:


Years Active: 1982-2006

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Claude Bernhart: Innovator in Cardiovascular Medicinal Products

Introduction

Claude Bernhart is a notable inventor based in Saint Gely du Fesc, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating cardiovascular conditions. With a total of 12 patents to his name, Bernhart's work has had a considerable impact on the pharmaceutical industry.

Latest Patents

Bernhart's latest patents include innovative compounds such as aminoalkoxybenzoyl-benzofuran and benzothiophene derivatives. These compounds are characterized by their potential use as medicinal products, specifically targeting pathological syndromes of the cardiovascular system. His inventions detail methods for preparing these derivatives and the pharmaceutical compositions that incorporate them, showcasing their therapeutic applications.

Career Highlights

Throughout his career, Claude Bernhart has worked with prominent companies in the pharmaceutical sector, including Sanofi and Elf Sanofi. His experience in these organizations has allowed him to refine his expertise in medicinal product development and patent innovation.

Collaborations

Bernhart has collaborated with notable professionals in his field, including Dino Nisato and Patrick Gautier. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Claude Bernhart's contributions to the field of medicinal chemistry, particularly in cardiovascular treatments, highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…